PitchSend

Investor Presentaiton

31st January 2024 Branded Generics in India & EM is sizeable part of the business US Generics 23% Africa 15% 9M FY 2024 Sales Rs. 3,121 cr. Africa Instn. 6% = EM Emerging Markets Asia 25% India 31% 71% Branded Generics 50% of our products are 1st to Market 500+ Brands across therapeutic segments 4,500+ Medical Representatives globally for promotion of products 6 ajanta

View entire presentation